# An Open Label Placebo Study to Assess the Inhalation Profile in Asthmatic Patients Using the Nexthaler® Dry Powder Inhaler (DPI) Device

> **NCT01651650** · PHASE2 · COMPLETED · sponsor: **Chiesi Farmaceutici S.p.A.** · enrollment: 41 (actual)

## Conditions studied

- Asthma

## Interventions

- **DEVICE:** Inhalation through Chiesi NEXThaler DPI

## Key facts

- **NCT ID:** NCT01651650
- **Lead sponsor:** Chiesi Farmaceutici S.p.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2012-09
- **Final completion:** 2012-09
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2018-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01651650

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01651650, "An Open Label Placebo Study to Assess the Inhalation Profile in Asthmatic Patients Using the Nexthaler® Dry Powder Inhaler (DPI) Device". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01651650. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*